Market Leadership Alembic Pharmaceuticals holds a dominant position in India's anti-infective segment, particularly in Macrolides, indicating strong brand recognition and customer loyalty which can be leveraged for expanding product portfolios.

Manufacturing Capacity With the largest fermentation capacity in India at Vadodara and state-of-the-art facilities in Vadodara and Baddi, the company presents significant manufacturing scalability, making it a reliable partner for large-volume pharmaceutical contracts.

Research & Development The presence of a modern research center enables Alembic to innovate and develop new formulations, offering opportunities for collaborative R&D projects or access to upcoming proprietary products.

Global Compliance Having US FDA-approved plants positions Alembic as a trusted manufacturer for international markets, creating potential for expanding export collaborations and supplying to high-regulatory-demand regions.

Financial Strength Generating revenues in the range of 1 to 10 billion dollars and employing over 10,000 staff, Alembic has robust financial backing, allowing flexibility for investments in new product development, strategic partnerships, or capacity expansion initiatives.